Lysosome membrane permeability: Implications for drug delivery

Advanced Drug Delivery Reviews

Volumn 41, Issue 2, 2000, Pages 189-200

  Lloyd, John B ^a  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

Author keywords

Drug delivery; Lysosomes; Membrane permeability

Indexed keywords

CONTROLLED DRUG DELIVERY; DIFFUSION; DRUG PRODUCTS; ENZYMES; HYDROGEN BONDS; MACROMOLECULES; METABOLISM; METABOLITES; MOLECULES; SUGAR (SUCROSE);

DRUG DELIVERY; EFFLUX; HYDROPHILICITY; INTRALYSOSOMAL CATABOLISM; LYSOSOME MEMBRANE PERMEABILITY; LYSOSOMES; PASSIVE DIFFUSION; PERMEANCE; XENOBIOTICS;

CELL MEMBRANES;

ANION; CATION; LYSOSOME ENZYME; MACROGOL; XENOBIOTIC AGENT;

DRUG DELIVERY SYSTEM; ENDOCYTOSIS; HYDROGEN BOND; HYDROPHILICITY; LIPID BILAYER; LYSOSOME; MEMBRANE PERMEABILITY; OSMOLARITY; PRIORITY JOURNAL; REVIEW;

EID: 0343067073     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(99)00065-4     Document Type: Article

References (36)

1. Berthet J., Bethet L., Appelmans F., de Duve C. Tissue fractionation studies. 2. The nature of the linkage between acid phosphatase and mitochondria in rat-liver tissue. Biochem. J. 50:1951;182-189.
2. de Duve C., Pressman B.C., Gianetto R., Wattiaux R., Appelmans F. Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue. Biochem. J. 60:1955;604-617.
3. de Duve C. The lysosome in retrospect. Dingle J.T., Fell H.B. Lysosomes in Biology and Pathology. Vol. 1:1969;3-40 North-Holland, Amsterdam.
4. de Duve C. Lysosomes as targets for drugs. Campbell P.N. The Interaction of Drugs and Subcellular Components in Animal Cells. 1968;155-169 Churchill, London.
5. de Duve C., de Barsy T., Poole B., Trouet A., Tulkens P., van Hoof F. Lysosomotropic agents. Biochem. Pharmacol. 23:1974;2395-2531.
6. Van Dyke R.W. Acidification of lysosomes and endosomes. Lloyd J.B., Mason R.W. Biology of the Lysosome. 1996;331-360 Plenum Press, New York.
7. Ashwell G., Morell A.G. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv. Enzymol. 41:1974;99-128.
8. Duncan R., Cable H.C., Lloyd J.B., Rejmanova P., Kopecek J. Degradation of side-chains of N-(2-hydroxypropyl)methacrylamide copolymers by lysosomal thiol-proteinases. Biosci. Rep. 2:1982;1041-1046.
9. Rejmanova P., Kopecek J., Duncan R., Lloyd J.B. Stability in rat plasma and serum of lysosomally degradable oligopeptide sequences in N-(2-hydroxypropyl)methacrylamide copolymers. Biomaterials. 6:1985;45-48.
10. Duncan R., Kopecek J., Rejmanova P., Lloyd J.B. Targeting of N-(2-hydroxypropyl)methacrylamide copolymers to liver by incorporation of galactose residues. Biochim. Biophys. Acta. 755:1983;518-521.
11. Duncan R., Seymour L.C.W., Scarlett L., Lloyd J.B., Rejmanova P., Kopecek J. Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats. Biochim. Biophys. Acta. 880:1986;62-71.
12. Duncan R., Kopeckova-Rejmanova P., Strohalm J., Hume I., Cable H.C., Pohl J., Lloyd J.B., Kopecek J. Anticancer agents coupled to of N-(2-hydroxypropyl)methacrylamide copolymers. I. Evaluation of daunomycin and puromcycin conjugates in vitro. Br. J. Cancer. 55:1987;165-174.
13. Duncan R., Kopeckova P., Strohalm J., Hume I., Lloyd J.B., Kopecek J. Anticancer agents coupled to of N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia. Br. J. Cancer. 57:1988;147-156.
14. Matsamura Y., Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanisms of tumoritropic accumulation of protein and the antitumor agent SMANCS. Cancer Res. 46:1986;6387-6392.
15. Vasey P.A., Kaye S.B., Morrison R., Twlves C., Wilson P., Duncan R., Thomson A.H., Murray L.S., Hilditch T.E., Murray T., Burtles D., Fraier D., Frigerio E., Cassidy J. Phase I clinical trial and pharmacokinetic study of PK1 (HPMA copolymer doxorubicin): first member of a new class of chemotherapeutic agents - drug-polymer conjugates. Clin. Cancer Res. 5:1999;83-94.
16. Lloyd J.B. Metabolite efflux and influx across the lysosome membrane. Lloyd J.B., Mason R.W. Biology of the Lysosome. 1996;361-386 Plenum Press, New York.
17. Lloyd J.B. Studies on the permeability of rat liver lysosomes to carbohydrates. Biochem. J. 115:1969;703-707.
18. Iveson G.P., Bird S.J., Lloyd J.B. Passive diffusion of non-electrolytes across the lysosome membrane. Biochem. J. 261:1989;451-456.
19. Stein W.D. The Movement of Molecules Across Cell Membranes. 1967;Academic Press, New York.
20. Diamond J.M., Wright E.M. Biological membranes: the physical basis of ion and nonelectrolyte selectivity. Annu. Rev. Physiol. 31:1969;581-646.
21. Piqueras A.I., Somers M., Hammond T.G., Strange K., Harris H.W., Gawryl M., Zeidel M.L. Permeability properties of rat renal lysosomes. Am. J. Physiol. 266:1994;C121-C133.
22. Andrew C.L., Klemm A.R., Lloyd J.B. Lysosome membrane permeability to amines. Biochim. Biophys. Acta. 1330:1997;71-82.
23. Moseley R.H., Van Dyke R.W. Organic cation transport by rat liver lysosomes. Am. J. Physiol. 268:1995;G480-G486.
24. Klemm A.R., Pell K.L., Anderson L.M., Andrew C.L., Lloyd J.B. Lysosome membrane permeability to anions. Biochim. Biophys. Acta. 1373:1998;17-26.
25. Pisoni R.L., Park G.Y., Velilla V.Q., Thoene J.G. Detection and characterization of a transport system mediating cysteamine entry into human fibroblast lysosomes. J. Biol. Chem. 270:1995;1179-1184.
26. Pisoni R.L., Thoene J.G., Christensen H.N. Detection and characterization of carrier-mediated cationic amino acid transport in lysosomes of normal and cystinotic human fibroblasts. J. Biol. Chem. 260:1985;4791-4798.
27. Cohn Z.A., Ehrenreich B.A. The uptake, storage, and intracellular hydrolysis of carbohydrates by macrophages. J. Exp. Med. 129:1969;201-225.
28. Ehrenreich B.A., Cohn Z.A. The fate of peptides pinocytosed by macrophages in vitro. J. Exp. Med. 129:1969;227-245.
29. Lloyd J.B. Experimental support for the concept of lysosomal storage disease. Hers H.G., van Hoof F. Lysosomes and Storage Diseases. 1973;173-195 Academic Press, New York.
30. Ohkuma S., Poole B. Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. J. Cell Biol. 90:1981;656-664.
31. Schulman J.D., Bradley K.H. The metabolism of amino acids, peptides, and disulfides in lysosomes of fibroblasts cultured from normal individuals and those with cystinosis. J. Exp. Med. 132:1970;1090-1104.
32. Duncan R., Rejmanova P., Kopecek J., Lloyd J.B. Pinocytic uptake and intracellular degradation of N-(2-hydroxypropyl) methacrylamide copolymers: a potential drug delivery system. Biochim. Biophys. Acta. 678:1981;143-150.
33. Lloyd J.B., Cable H.C., Rice-Evans C. Evidence that desferrioxamine cannot enter cells by passive diffusion. Biochem. Pharmacol. 41:1990;1361-1363.
34. Cable H., Lloyd J.B. Cellular uptake and release of two contrasting iron chelators. J. Pharm. Pharmacol. 51:1999;131-134.
35. Zelphati O., Szoka F.C. Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl. Acad. Sci. USA. 93:1996;11493-11498.
36. Klemm A.R., Young D., Lloyd J.B. Effects of polyethyleneimine on endocytosis and lysosome stability. Biochem. Pharmacol. 56:1998;41-46.